title: [Contemporary dietotherapy of the irritable bowel syndrome].
abstract: Irritable bowel syndrome (IBS) is the most prevalent functional disease of the gastrointestinal tract. This highly prevalent condition is best diagnosed by assessing the constellation of symptoms with which patients present to their physicians. Because some critics have previously questioned whether irritable bowel syndrome and other functional gastrointestinal disorders truly exist because they do not have defining structural features, the Rome Foundation fostered the use of symptom-based criteria for universal use. In most cases treatment is reduced to symptomatic therapy because a lot of unknown in pathogenesis by irritable bowel syndrome. Irritable bowel syndrome leads to decrease of quality of life of the patients and could be one of the reasons of patients' disability. Food is believed by patients promotes symptoms and the diet or avoiding specific food can reduce symptoms. Possible role of different food and microbiota in the pathophysiology of irritable bowel syndrome, as well as the data from randomized, controlled clinical trials dedicated to the effects of diet in irritable bowel syndrome are summarized and discussed in this review. The efficacy of the diet, enriched by fiber, prebiotics, probiotics, peppermint oil, curcumin and vitamin B6 in irritable bowel syndrome patients was shown in numerous studies. In some studies restriction in consumption of fermented carbohydrates, coffee and alcohol, as well as diet with elimination IgG-sensed food was also shown to be effective in irritable bowel syndrome. Food intolerances, defined as non-toxic non-immune adverse reactions to food, include reactions to bioactive chemicals in foods and metabolic reactions to poorly absorbed dietary carbohydrates. New dietary approaches like polyunsaturated fatty acids intake correction and the low tryptophan intake are discussed.
authors.forename: V I
authors.initials: VI
authors.lastname: Pilipenko
authors.forename: E A
authors.initials: EA
authors.lastname: Burliaeva
authors.forename: V A
authors.initials: VA
authors.lastname: Isakov
mesh_terms: D004032:Diet / Q000009:adverse effects / Q000379:methods*; D019587:Dietary Supplements; D005231:Fatty Acids, Unsaturated / Q000627:therapeutic use*; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000178:diet therapy* / Q000276:immunology / Q000378:metabolism
chemical_list: D005231:Fatty Acids, Unsaturated